Successful treatment of sudden sensorineural hearing loss by means of pharmacotherapy combined with early hyperbaric oxygen therapy: Case report. | Canada Hyperbarics Skip to main content
Clinical Guideline Medicine 2017

Successful treatment of sudden sensorineural hearing loss by means of pharmacotherapy combined with early hyperbaric oxygen therapy: Case report.

Olex-Zarychta D — Medicine, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report detailing the treatment of a 44-year-old woman with sudden sensorineural hearing loss using corticosteroids and hyperbaric oxygen therapy.

What They Found

A 44-year-old woman diagnosed with unilateral sudden idiopathic sensorineural hearing loss received 15 daily 1-hour exposures to 100% oxygen at 2.5 atmosphere absolute, combined with oral high-dose corticosteroids. This combined treatment led to a full recovery of her hearing.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a single case report, this study's findings are limited by the lack of generalizability and the absence of a control group.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 29390550
Year Published 2017
Journal Medicine
MeSH Terms Administration, Oral; Adult; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Hearing Loss, Sensorineural; Humans; Hyperbaric Oxygenation; Prednisone

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology